Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Early Systemic Sclerosis by Bosentan

NCT00226889 is registered in ClinicalTrials.gov with Rikshospitalet University Hospital as lead sponsor.

NCT NCT00226889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Early Systemic Sclerosis by Bosentan
Lead sponsor
Rikshospitalet University Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2005
Completion date
June 30, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis (scleroderma)